Compare Salesforce Inc (CRM) vs Davita Inc (DVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Salesforce Inc vs Davita Inc — how do they compare? Salesforce Inc trades at $196.69 (market cap $161.76B), while Davita Inc trades at $178.34 (market cap $11.72B). The key difference: Salesforce Inc is far larger — about 13.8× Davita Inc's market cap, and Salesforce Inc pays a 0.89% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| CRM | DVA | |
|---|---|---|
Market Cap | $161.76B | $11.72B |
Sector | Technology | Health |
52-Week High | $266.23 | $240.96 |
52-Week Low | $150.12 | $103.87 |
Enterprise Value | $191.81B | $24.44B |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Salesforce (CRM) trades at $197.51, up 2.47% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $3.88 exceeding expectations of $3.13. Revenue growth accelerated to $37.90 billion in 2025, while net income margin improved to 16.35%. Analyst consensus remains strongly bullish with a $230.61 price target.
Outlook: Salesforce demonstrates robust fundamentals with high profitability and consistent earnings outperformance, supported by AI monetization growth. Risks include competitive pressures in SaaS and macroeconomic volatility affecting tech stocks. The stock offers potential upside to analyst targets if execution continues.
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Salesforce Inc
Salesforce Inc provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.
Read more on CRM →About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →
